Hanson McClain Advisors »

Pieris Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Pieris Pharmaceuticals (PIRS) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Pieris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pieris Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pieris Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $64 350 0.19
2023-12-31 $64 350 0.18
2023-09-30 $105 350 0.30
2023-06-30 $57 350 0.17
2023-03-31 $341 350 0.98

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)

View all positions for Hanson McClain Advisors

Top funds holding Pieris Pharmaceuticals

BVF
Lynx1 Capital Management
Citadel Advisors
Vanguard Group
CM Management
Millennium Management
Summit Trail Advisors
Virtu Financial
Citigroup
Two Sigma Investments
NorthStar Asset Management
Two Sigma Advisers
Raymond James & Associates
NJ State Employees Deferred Compensation Plan
Goldman Sachs Group

View all funds holding Pieris Pharmaceuticals